Published Mar 13, 2023
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
Explore the efficacy of the new Alzheimer's drug, lecanemab, and its limitations for high-risk groups as neurology expert Jonathan Jackson delves into the critical need for diversity and innovative design in clinical trials to improve treatment outcomes across different populations.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
A New Drug For A Relentless Brain Disease
Answers 383 questions
Depression And Alzheimer's Treatments At A Crossroads
Answers 383 questions
One More Step Toward Solving The Sleep & Alzheimer's Puzzle
Answers 383 questionsThree Sisters And The Fight Against Alzheimer's Disease
Answers 383 questions
A Brand New Kind of Schizophrenia Treatment
Answers 383 questions
There's A Plan To Drive Down Global Insulin Prices. Will It Work?
Answers 383 questions
A COVID-19 Vaccine: What You Need To Know
Answers 383 questionsThe Evolution Of HIV Treatment
Answers 383 questions
What A New Antiviral Drug Could Mean For The Future Of COVID
Answers 383 questionsMeet The Dermatologists Advancing Better Care For Skin Of Color
Answers 383 questionsShould Black People Get Race Adjustments In Kidney Medicine?
Answers 383 questions
Does Your Dog REALLY Love You?
Answers 383 questionsHow COVID-19 Has Changed Science
Answers 383 questionsDo You See What I See?
Answers 383 questionsHelping A Man Walk Again With Science
Answers 383 questions